Neuroscience & Mental Health

← Back to Neuroscience

Neural bases of psychiatric conditions, psychopharmacology, and brain–behavior links.

Welcome to the Neuroscience & Mental Health section, where we investigate the neural bases of psychiatric conditions, psychopharmacology, and brain–behavior links. Modern clinical research is rapidly dismantling outdated myths—such as oversimplified views on dopamine detoxes or rigid stages of grief—replacing them with precise, mechanistic insights into how neural circuits, genetics, and systemic pathways govern human behavior.

Our coverage spans the molecular and systemic pathways of psychiatric disorders. We explore how psychoneuroimmunology connects chronic stress, HPA axis and sympathetic nervous system dysregulation, and neuroinflammation to systemic immune alteration, anxiety, and cognitive decline. This includes examining the molecular drivers of major depressive disorder, such as glutamatergic excitotoxicity and Default Mode Network hyperconnectivity, as well as the role of the gut-brain axis and tryptophan metabolism in regulating serotonin and mood. We also examine behavioral modulators, deconstructing misconceptions surrounding testosterone's role in status-seeking, and investigating how interoception serves as a transdiagnostic mechanism across anxiety, depression, and trauma.

This section also highlights the neurobiology of trauma, social dynamics, and environmental influences. Research reveals how psychological trauma alters neural circuitry, leaving molecular signatures that can be inherited across generations through epigenetic mechanisms like DNA methylation and histone modification. We analyze the neural distinctions between the chronic stress of loneliness and the parasympathetic recovery of solitude, the brain's survival response to public speaking, the atypical connectivity underlying social cognition in autism, and how systemic workplace stress alters the brain in occupational burnout. Conversely, we look at restorative inputs, such as how nature immersion modulates amygdala activity to reduce stress.

Finally, we evaluate therapeutic mechanisms and recovery. We detail how the brain heals from addiction and trauma through prefrontal cortex repair and neuroplasticity, and how interventions—including clinical vagus nerve stimulation, exposure therapy, therapeutic journaling, GLP-1 receptor agonists, and classic psychedelics—modulate reward pathways, fear responses, and global network connectivity. Through computational psychiatry and mathematical modeling, we translate these complex biological phenomena into clearer frameworks for clinical understanding.

28 published articles